Media OutReach
International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM) gathers global experts in Chinese Medicine
Concurrent Food Expo features “Multi-Facets of Chinese Medicine” exhibition
HONG KONG SAR – Media OutReach Newswire – 20 July 2026 – The 25th International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), organised by the Modernized Chinese Medicine International Association (MCMIA) together with the HKTDC and ten scientific research institutions, will be held from 13 to 15 August at the Hong Kong Convention and Exhibition Centre (HKCEC), offering industry professionals the latest insights into Chinese medicine. This year’s conference is funded by the Chinese Medicine Development Fund of the Government of the Hong Kong Special Administrative Region. It is dedicated to strengthening the ties between Hong Kong’s Chinese medicine industry and the international market, while promoting Hong Kong’s leading role in the global field of Chinese medicine.
Register for the conference to stay updated with the latest industry information on Chinese medicine: https://tinyurl.com/tmvryr38
Aligning with the strategic Blueprint with a focus on “Bringing In and Going Global”
The Chinese Medicine Development Blueprint of Hong Kong (the Blueprint) released in 2025 positions Hong Kong as a bridgehead for the global internationalisation of Chinese medicine and a key highland within the national framework for Chinese medicine development. To actively support the strategic direction of the Blueprint, this year’s conference adopts the theme Clinical Translation, Regulatory Policies and Global Innovative Pathways of Traditional Medicine, focusing on two core elements: bringing in and going global. It introduces Hong Kong’s Chinese medicine regulations and resource support to participants from Chinese Mainland and overseas, while inviting overseas regulatory authorities to share their local traditional medicine regulations. This year, some 30 experts and scholars from Hong Kong, Chinese Mainland, and overseas have been invited to comprehensively explore the latest research and development trends, regulatory interpretations, and success cases in Chinese medicine.
The three-day conference is divided into five major thematic sessions, covering policy blueprints, international regulations, clinical research, success case sharing, and talent cultivation:
To help enterprises from Chinese Mainland and abroad understand Hong Kong’s Chinese medicine regulation and support, Dr. Vincent Chung Chi-ho, Commissioner for Chinese Medicine Development, Chinese Medicine Unit, Health Bureau, will elaborate on the Blueprint, while Law Kwok-wai, Robert, Chief Pharmacist (Chinese Medicine), Chinese Medicine Regulatory Office, Department of Health, Dr. Yeung Kin Wai, Senior Chemist, Government Chinese Medicines Testing Institute, Department of Health, and Prof. Bian Zhaoxiang, Hospital Chief Executive, The Chinese Medicine Hospital of Hong Kong (CMHHK) , will share in-depth insights into the latest progress in Chinese medicine regulation, quality standards testing, and clinical practice and research at the Chinese Medicine Hospital. Furthermore, Arnold Lau, Associate Director-General, Invest Hong Kong, Dr. William Cheung, Deputy Chief Manager (Life and Health Technology), Office for Attracting Strategic Enterprises (OASES), Angela Yu, Deputy Head of Health Tech and TCM, Hong Kong Productivity Council and Wing Chu, Deputy Director of Research, HKTDC, will participate in a panel discussion to analyse the Hong Kong government’s resource support for the development of Chinese medicine.
To provide attendees with a comprehensive analysis of market trends, Prof. Zheng Linyun, Executive Vice President of the Shanghai Academy of International Standardization of Traditional Chinese Medicine, will share reflections and prospects on the transformation of ISO/TC249. Furthermore, Prof. Taruna Ikrar, Chairperson of the Indonesian Food and Drug Authority (BPOM), Indonesia, Nurul Anisah Binti Shahri from National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia and Thawatchai Nakkaratniyom, Senior Professional Level Pharmacist, Head of Pre-marketing Control Group, Herbal Products Division at Thai Food and Drug Administration, Ministry of Public Health, Thailand will jointly analyse the regulations and standards of the Southeast Asian market.
Scientific and clinical experts will share the latest progress in the scientific research and clinical application of Chinese medicine, as well as experiences regarding the R&D application and clinical efficacy of hospital-made Chinese medicine preparations. Prof. Zhang Zhongde, Deputy President of Guangzhou University of Chinese Medicine & President of Guangdong Provincial Hospital of Chinese Medicine will share Chinese Mainland’s practices in the research and development of Chinese medicine. Prof. Lee Sanghoon, Dean, International Education Institute of Korean Medicine, Kyung Hee University will discuss the development of new natural product drugs in Korea. Prof. Pei Xiaohua, Dean of Changping Hospital Affiliated to Beijing University of Chinese Medicine and Director of the Institute of Traditional Chinese Surgery will discuss clinical needs in developing new Chinese herbal medicines for TCM-advantageous breast diseases. Locally, Prof. Zhang Ge from Hong Kong Baptist University will present innovative achievements in utilising traditional Chinese medicine to drive target discovery for triple-negative breast cancer, while Prof. Xian Yanfang Lisa, Assistant Professor, School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong will share pre-clinical and clinical studies of novel Chinese medicine formula for treating gout.
Focusing on successful industry practices, ICMCM provides an interactive platform for the industry, helping to ensure the continuous development and growth of the traditional Chinese medicine sector. Yan Han, Chairman, Beijing Tong Ren Tang Chinese Medicine Company Limited will share the cultural heritage and internationalised development of Chinese medicine, and Dr. Celine Cheng, Chief Compliance & Technology Officer of Jacobson Pharma Corporation Limited will share GMP applications in the industry. Several professors from Chinese Mainland, Australia, Canada, Macao, and Singapore—including Prof. Li Min, Dean and Chair Professor, School of Chinese Medicine, Hong Kong Baptist University; Prof. Xu Hongxi, Chairman, Belt and Road Alliance for Traditional Medicine, Honorary Dean & Distinguished Professor, Shanghai University of Traditional Chinese Medicine; Prof. Zhu Xiaoshu, Co-Director, Australia-China Chinese Medicine Centre, Western Sydney University, Australia; and Prof. Linda Zhong, Director, Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore —will explore training models for Chinese medicine talent at home and abroad, alongside market demands for Chinese medicine products in potential markets.
The Symposium will be held on the morning of 15 August. This year, it is jointly organized by eight institutions, including four Hong Kong universities—The Chinese University of Hong Kong, The University of Hong Kong, Hong Kong Baptist University, and The Hong Kong University of Science and Technology—alongside Nanyang Technological University in Singapore, the University of Macau, Shanghai University of Traditional Chinese Medicine, and Guangzhou University of Chinese Medicine. The Symposium will kick off with Vincent & Lily Woo Fellowship in Memory of Dr Albert Wong endowed by Vincent & Lily Woo Foundation Award Presentation Ceremony, hosted by the Modernized Chinese Medicine International Foundation. This year’s Symposium will feature nearly 100 research presentations, including oral research presentations by 10 postgraduate students from Hong Kong, Chinese Mainland, Australia, Singapore, South Korea, Vietnam, and Serbia, and nearly 90 poster displays. The judging panel will select 10 winners for the Tianjiang Cup Li Shizhen Youth Outstanding Thesis Award. The Symposium not only provides a platform for postgraduate students in Chinese medicine to share their research progress and achievements but also promotes student collaboration and exchange, laying an important cornerstone for cultivating a new generation of scientific research professionals and driving the development of Chinese medicine.
This year’s conference continues to operate under the hybrid model, with simultaneous interpretation in both English and Putonghua offered to enable wider industry participation.
In addition to the professional conference tailored for industry practitioners, ICMCM is committed to promoting the popularisation and implementation of Chinese medicine in the community through a public education display area titled “Multi-Facets of Chinese Medicine” at the concurrent Food Expo. In response to the directives of the Blueprint, this interactive and educational display aims to significantly enhance the public’s correct understanding of and confidence in Chinese medicine.
The design of the exhibition is closely aligned with the development direction set out in the Blueprint, providing a comprehensive overview of the new chapter in Hong Kong’s Chinese medicine sector. It covers four main themes including the latest development trends of Chinese medicine in Hong Kong, the service features of the Chinese Medicine Hospital of Hong Kong, the Hospital Authority’s Chinese medicine outpatient services, Chinese medicine regulation framework and Chinese medicine practitioner registration system, alongside knowledge on Chinese medicine wellness practices.
A half-day ICMCM Public Forum will be held on Saturday, 15, August 2026, to promote the advantages of Chinese medicine services, interesting Chinese medicine wellness tips and preventive healthcare. By running industry conferences alongside public exhibitions and forums in parallel, the event aims, on the one hand, to foster academic and industrial innovation exchanges among global Chinese medicine experts, and on the other, to embed Chinese medicine culture deeply into the daily lives of the public, thereby jointly promoting Hong Kong’s development as an international centre for Chinese medicine.
Conference programme: icmcm.hktdc.com/pdf/2026/programme.pdf
Website: hktdc.com/icmcm
Concurrent Exhibitions:
HKTDC Food Expo PRO foodexpopro.hktdc.com
HKTDC Hong Kong International Tea Fair hkteafair.hktdc.com
HKTDC Food Expo hkfoodexpo.hktdc.com
HKTDC Beauty & Wellness Expo hkbeautyexpo.hktdc.com
HKTDC Home Delights Expo homedelights.hktdc.com
Hashtag: #HKTDC #ICMCM
The issuer is solely responsible for the content of this announcement.
Media OutReach
TELOSIN Introduces “The Dual Transformation,” Pairing Y PRO Red and Y PRO Blue with the New Lumiactive Collection
The new skincare system brings together FDA-cleared, NASA-inspired light technology, complementary formulations and award-winning patented design by Karim Rashid, following a Hong Kong launch attended by more than 2,000 guests
HONG KONG SAR – Media OutReach Newswire – 21 July 2026 – TELOSIN has introduced “The Dual Transformation,” a new approach to personalised at-home skincare built around two dedicated light-based beauty devices—the Y PRO Red and Y PRO Blue—and the complementary Lumiactive Collection.
The launch brings together advanced light-based technology, targeted skincare formulations and award-winning patented design created in collaboration with internationally acclaimed designer Karim Rashid.
Rather than incorporating multiple generalised modes within a single device, TELOSIN developed two distinct devices and two dedicated skincare pathways.
Y PRO Red is designed for a rejuvenation-focused skincare routine, supporting the appearance of firmness, texture and radiance.
Y PRO Blue is designed for routines focused on blemish-prone, oily or visibly unsettled skin.
The devices combine FDA-cleared technology with light-based innovation inspired by scientific developments associated with NASA research.
Introducing the Lumiactive Collection
The Y PRO devices are accompanied by the new Lumiactive Collection, comprising:
- LUMIRED Red LED Treatment Gel
- LUMIBLUE Blue LED Treatment Gel
- Blue Light Defense Cream
Together, the devices and complementary formulations establish TELOSIN’s connected Prepare, Treat, Protect approach to skincare.
The dedicated Lumiactive treatment gels are designed to prepare the skin for the corresponding Y PRO routine, while Blue Light Defense Cream completes the ritual as part of the brand’s wider daily skincare approach.
By developing the devices and formulations as one connected collection, TELOSIN aims to make advanced light-based skincare easier to understand, personalise and incorporate into regular at-home routines.
The result is a complete ecosystem built around two targeted transformations: a red-light pathway focused on rejuvenation and a blue-light pathway focused on skin clarity and balance.
Scientific Insight Behind TELOSIN
TELOSIN has expanded the scientific conversation surrounding the launch through its expert video series, “The Science Behind Telosin,” available on the brand’s website.
The series features expert perspectives from two medical professionals:
Dr. Omer Wolf, MD, a specialist in plastic and reconstructive surgery and advanced facial aesthetic procedures.
Dr. Uri Berger, MD, a specialist in aesthetic medicine with extensive international medical training and experience.
Through the expert series, TELOSIN provides consumers with accessible information about the principles behind light-based skincare and the evolving relationship between professional aesthetic knowledge, beauty technology and at-home routines.
The inclusion of medical perspectives within the wider educational programme reflects TELOSIN’s commitment to supporting product innovation through informed scientific discussion and responsible consumer education.
Award-Winning Patented Design by Karim Rashid
The Y PRO Red and Y PRO Blue were created in collaboration with Karim Rashid, one of the world’s most recognised contemporary designers.
The devices feature award-winning patented design that combines Rashid’s distinctive visual language with TELOSIN’s advanced beauty technology.
Their fluid silhouettes, individual colour identities and ergonomic forms were developed not simply to contain sophisticated technology, but to transform the devices into desirable contemporary objects that can become a natural part of the user’s daily beauty environment.
The collaboration reflects TELOSIN’s belief that advanced skincare devices should deliver a sophisticated combination of performance, simplicity, comfort and emotional connection.
“The Dual Transformation” Unveiled to More Than 2,000 Guests in Hong Kong
The complete collection was officially presented on 30 June 2026 through “The Dual Transformation,” an immersive launch experience held at WTC Mall in Hong Kong.
The large-scale event welcomed more than 2,000 guests, including consumers, members of the Hong Kong media, influencers, beauty industry professionals and invited partners.
The launch featured internationally acclaimed designer Karim Rashid, MIRROR member Ian Chan, celebrated actress and singer Linda Chung, and Dr. Harvey Ho.
Karim Rashid introduced the creative thinking behind the award-winning patented design of the devices, while Dr. Harvey Ho discussed the different applications and skincare pathways associated with red and blue light technology.
Ian Chan and Linda Chung joined the launch presentation to experience the two routines and demonstrate how the Y PRO devices and complementary Lumiactive formulations can be incorporated into contemporary at-home skincare.
“The Dual Transformation demonstrates that advanced beauty technology does not need to feel clinical or complicated,” said Dr. Harvey Ho.
“By bringing together two dedicated light-based devices with complementary Lumiactive formulations, TELOSIN has created a more focused and intuitive approach to at-home skincare. The distinction between the red and blue light pathways also helps consumers better understand how different technologies can support different skincare needs.”
With more than 2,000 guests attending, the event marked a major public introduction of TELOSIN’s broader product ecosystem: two targeted devices, three complementary skincare formulations and one connected approach to personalised light-based skincare.
A Complete Dual Skincare System
With Y PRO Red, Y PRO Blue and the Lumiactive Collection, TELOSIN is introducing more than two individual beauty devices.
“The Dual Transformation” represents a complete skincare system built around clearly defined objectives, dedicated formulations and award-winning patented design.
It reflects the brand’s wider ambition to make sophisticated light-based technology more personalised, intuitive and accessible, while maintaining the premium design experience expected by contemporary beauty consumers.
Hashtag: #TELOSIN
https://www.telosin.com
https://www.instagram.com/telosin_official/?hl=en
The issuer is solely responsible for the content of this announcement.
About TELOSIN
TELOSIN develops premium at-home skincare devices and complementary formulations that bring together advanced light-based technology, scientific insight, award-winning patented design and an intuitive user experience.
Through continued product development and collaborations with internationally recognised designers and medical professionals, TELOSIN aims to make sophisticated beauty technology more personalised, accessible and desirable.
TELOSIN products are available online at
www.telosin.com, at The Mineral Boutique stores, through selected premium retailers and at leading clinics.
For further information, expert videos and product details, visit
www.telosin.com.
Media OutReach
SearchInform: A Risky Game – How FIFA World Cup 2026 Led to Mass Corporate Data Leaks
Experts claim that corporate employees in Southeast Asia are neglecting cybersecurity rules due to their love for football, leading to an increase in fraud cases.
SINGAPORE – Media OutReach Newswire – 21 July 2026 – Although the tournament itself took place in North America, Asia’s massive football fan base created the perfect conditions for data leaks.
Fraudsters are capitalizing on football fans by creating fake streaming platforms and malicious Android applications that steal saved passwords and account credentials directly from browsers. Criminals are also setting up fraudulent websites, as well as sending phishing emails to company employees disguised as gifts, promotions, and office betting pools.
“During major global events, the corporate security perimeter is under huge stress,” said Francis Yeoh, Country Director at SearchInform Malaysia. “Employees access streaming websites from corporate devices to watch matches live. Traditional network-edge security is insufficient—the real danger comes from the employee side of the fence. Employees could watch a translation on a malware-infested website, they could download streaming applications with hidden malware, or use corporate credentials to register for fraudulent giveaways.”
According to Group-IB and the FBI, from August 2025 to June 2026, more than 4,300 fake websites were registered fully mimicking FIFA interfaces, ticketing systems, streaming platforms, and World Cup employment portals.
How Organizations Can Reduce Cyber Risks During Football Season
- Monitor the use of corporate devices. Remind employees that corporate workstations should not be used for personal purposes, including streaming, downloading unofficial apps, or visiting suspicious websites. This measure alone can help reduce exposure to many malware threats.
- Strengthen password security. Monitor risky password practices, as some employees may reuse corporate credentials for personal services. If one of these services is compromised, corporate accounts and systems may be put at risk as well.
- Enforce multi-factor authentication. Apply MFA for privileged employees on a regular basis and temporarily strengthen authentication requirements for remote employees during high-risk periods. This provides an additional layer of protection against unauthorized access.
- Monitor data access patterns. Track who accesses critical information, from where, and monitor its transmission to prevent data loss. Make sure protection also covers cloud services, as corporate data is no longer limited to on-premises storage.
Hashtag: #SearchInform #Cybersecurity, #FIFA2026, #DataProtection
The issuer is solely responsible for the content of this announcement.
About SearchInform
SearchInform is an information security and risk management product vendor as well as an MSS provider. The company’s clients are more than 4000 companies in 20+ countries. Today, the team has products and services for comprehensive protection against insider threats at all levels of corporate information systems: FileAuditor (the DCAP class solution); DLP system with extended functionality; Risk Monitor (advanced AI-powered platform for internal threat mitigation); SIEM system, Information Security outsourcing service.
Media OutReach
Malaysian Companies Invited to Register for INSP MIHAS 2026
More than 500 international buyers from 55 economies have confirmed participation
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 21 July 2026 – The Malaysia External Trade Development Corporation (MATRADE) invites Malaysian companies to seize new global business opportunities by registering for its flagship International Sourcing Programme (INSP) at the upcoming 22nd Malaysia International Halal Showcase (MIHAS) at MITEC, Kuala Lumpur from 23 to 26 September 2026.
Building on the strong momentum of INSP MIHAS 2025, which generated RM3.63 billion in sales, this year’s edition is seeing strong international buyer interest, reinforcing MIHAS’ position as a leading global halal trade platform. INSP MIHAS 2026 features key products and services categories including:
- Agricultural Produce;
- Apparel, Garments and Accessories;
- Beverages;
- Education;
- Fashion Accessories and Textiles;
- Footwear;
- Franchise;
- Gifts, Souvenirs and Jewellery;
- Gloves;
- Islamic Financial Services;
- Information and Communication Technology;
- Logistics;
- Machinery and Equipment;
- Packaging and Containers;
- Palm Oil Products;
- Pet Products;
- Pharmaceuticals;
- Toiletries and Cosmetics; and
- Prepared Food.
Beyond the conventional halal food and beverage segment, this year’s edition is also seeing growing interest in services sectors.
INSP MIHAS connects pre-qualified international buyers with Malaysian halal product and service exporters through pre-arranged one-on-one business meetings across key halal sectors. As buyer meeting slots are limited and allocated through a structured matching process, Malaysian companies are strongly encouraged to register early via the online portal.
According to MATRADE’s Chief Executive Officer (CEO), Mr. Abu Bakar Yusof, “Since the inception of MIHAS in 2004, the International Sourcing Programme (INSP) has generated over RM20.62 billion in export sales for Malaysian companies, with the participation of nearly 8,000 international buyers, benefiting 10,600 Malaysian sellers through 67,200 structured business meetings.
For this year, we are targeting the participation of approximately 300 buyers, of which 50 are premium buyers, reflecting our commitment to attracting high-quality decision-makers and creating greater business opportunities for Malaysian companies. We are also targeting RM2 billion in export sales under the INSP component for MIHAS 2026. To date, we have received interest from more than 500 international buyers across 55 economies, and we encourage Malaysian companies to register early to maximise their business matching opportunities.”
MIHAS 2026 is expected to generate total sales of RM4.50 billion, including export sales from the INSP. “As it stands, 15% of the interested buyers comprise returning buyers, demonstrating sustained confidence in Malaysian exporters and the compelling value proposition they continue to offer in global markets,” he added. This year’s INSP has attracted buyers from 55 different economies.
Malaysian exporters can register through the INSP MIHAS online portal and MADANI Digital Trade Platform (MDTP) before 31st July 2026 and take advantage of one of MIHAS’ most impactful business matching initiatives.
Hashtag: #MIHAS2026
The issuer is solely responsible for the content of this announcement.
Malaysia External Trade Development Corporation (MATRADE)
For more information, please contact:
Aninawati Saleh
Head of Corporate Communication
Malaysia External Trade Development Corporation (MATRADE)
Tel (Direct) : 03 – 6207 7077 (7826)
Email : co***********@*********ov.my
About Malaysia International Halal Showcase (MIHAS) 2026
Since it began in 2004, the Malaysia International Halal Showcase (MIHAS) has grown into a major platform for Halal trade and has helped strengthen the global industry’s position in Halal standards, governance, and market access. Recognised as a Guinness World Records holder and hosted by the Ministry of Investment, Trade and Industry (MITI) with the Malaysia External Trade Development Corporation (MATRADE) as organiser, MIHAS now covers 14 sectors, from food and beverages and pharmaceuticals to Islamic finance, modest fashion, personal care, technology, services, and Muslim-friendly tourism. The 22nd edition of MIHAS, themed “Shaping Trust, Driving Resilience”, will focus on regulated-by-design governance and technology-enabled trade.
About MATRADE
The Malaysia External Trade Development Corporation (MATRADE) was established on 1 March 1993 as the national trade promotional arm under Malaysia’s Ministry of Investment, Trade and Industry (MITI).
MATRADE’s primary role is to assist Malaysian exporters in developing and expanding their export markets. Aligned with Malaysia’s commercial diplomacy efforts, MATRADE is the nation’s trade facilitator and champion of Malaysian-made products and services on the global stage.


